Omega Healthcare Investors Inc.
OHI
$45.50
+0.64%
Omega Healthcare Investors Inc. is a real estate investment trust (REIT) specializing in healthcare-related real estate, primarily skilled nursing facilities, assisted living facilities, and other senior housing properties across the United States, United Kingdom, and Canada. The company operates as a capital partner, leasing properties to third-party healthcare operators, which positions it as a critical financier within the post-acute care real estate sector. The current investor narrative revolves around the stability and recovery of its operator base following industry-wide pressures, with attention focused on its ability to maintain its dividend—evidenced by a payout ratio exceeding 100%—and navigate the ongoing challenges in the skilled nursing reimbursement and occupancy environment.…
OHI
Omega Healthcare Investors Inc.
$45.50
Related headlines
Investment Opinion: Should I buy OHI Today?
Rating & Thesis: Hold. OHI presents a conflicted profile where strong cash-generating fundamentals are overshadowed by technical breakdown and dividend coverage concerns, resulting in a neutral near-term outlook. The limited analyst coverage and 'Sector Perform' consensus suggest a wait-and-see approach is prudent. Supporting Evidence: The recommendation is anchored by four key data points: 1) A forward P/E of 21.41x, which is reasonable but not cheap for its sector; 2) Robust revenue growth of 15.22% YoY; 3) Exceptional TTM free cash flow of $859.8 million that supports operations; and 4) A high dividend yield of 5.94% that provides income support. However, the elevated P/S ratio of 10.96x and the earnings payout ratio over 100% temper enthusiasm for an outright Buy rating. Risks & Conditions: The two biggest risks are a dividend cut triggered by cash flow disruption and continued multiple compression from sector outflows. This Hold rating would upgrade to a Buy if the stock stabilizes above its 52-week low and the payout ratio based on earnings moves sustainably below 100%. It would downgrade to a Sell if the price breaks decisively below the $35.70 support level or if TTM free cash flow shows a sequential decline. The stock is currently fairly valued relative to its own growth (PEG 0.78) but carries a premium on sales, making the overall valuation assessment neutral.
Sign up to view all
OHI 12-Month Price Forecast
The AI assessment is neutral with medium confidence. OHI is a tale of two stories: its financial engine (revenue growth, cash flow, balance sheet) is fundamentally sound, but its stock price is telling a story of distress and skepticism. The high yield and cash flow support a floor, but the technical breakdown and dividend coverage concerns cap near-term upside. The stance would upgrade to bullish on a confirmed technical reversal above the $47-48 resistance zone coupled with evidence of improving earnings-based payout metrics. It would turn bearish on a breakdown below $35.70, which would signal the fundamental story is breaking.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omega Healthcare Investors Inc.'s 12-month outlook, with a consensus price target around $59.15 and implied upside of +30.0% versus the current price.
Average Target
$59.15
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$36 - $59
Analyst target range
Analyst coverage is limited, with only 3 analysts providing estimates, which is low for a mid-cap REIT and can lead to higher volatility and less efficient price discovery. The consensus sentiment appears neutral to cautiously optimistic, as evidenced by recent institutional ratings which include actions like 'Equal Weight' from Wells Fargo and 'Sector Perform' from RBC Capital, though there was a downgrade from BMO Capital to 'Market Perform' in January 2026. The average revenue estimate for the upcoming period is $1.14 billion, with a range from $1.10 billion to $1.21 billion, indicating moderate growth expectations. The target price range is not explicitly provided in the data, but the pattern of recent ratings suggests a lack of strong conviction for significant upside in the near term. The low number of covering analysts implies that the stock may be under-followed by the broader institutional community, which can be both a risk and an opportunity. A wide dispersion in estimates or targets, if it existed, would signal high uncertainty, but the limited data suggests a more muted, wait-and-see approach among the few firms that do cover OHI, likely tied to the ongoing scrutiny of the healthcare operator environment and dividend sustainability.
Bulls vs Bears: OHI Investment Factors
The investment debate for OHI centers on a clash between strong underlying fundamentals and severe negative price momentum. The bull case is supported by robust 15.2% revenue growth, exceptional free cash flow, a healthy balance sheet, and an attractive 5.94% yield. The bear case is driven by a dividend not covered by earnings, a pronounced technical breakdown with significant underperformance, and premium valuations on certain metrics. Currently, the bearish technical and sentiment evidence appears stronger, as the stock's price action reflects deep skepticism despite solid financials. The single most important tension is whether the company's substantial free cash flow ($859.8M TTM) can sustainably support the dividend and validate the current valuation, or if sector headwinds and earnings coverage concerns will continue to drive capital away.
Bullish
- Strong Revenue Growth & Profitability: Q4 2025 revenue grew 15.22% YoY to $321.8 million, indicating robust portfolio performance. This is supported by a high net margin of 51.18% and an operating margin of 63.49%, demonstrating the efficiency of the triple-net lease model.
- Exceptional Free Cash Flow Covers Dividend: TTM free cash flow of $859.8 million provides a substantial cushion for the dividend, despite a payout ratio of 132.24% based on earnings. This strong cash generation underpins financial flexibility and dividend sustainability.
- Healthy Balance Sheet with Low Leverage: A debt-to-equity ratio of 0.82 is conservative for a REIT, and a current ratio of 3.46 indicates ample liquidity. This financial strength supports the company's ability to navigate operator challenges and fund growth.
- Attractive Dividend Yield: The current yield of 5.94% is a key attraction for income investors, especially in a low-volatility stock with a beta of 0.587. This yield provides a significant income cushion against potential price depreciation.
Bearish
- Dividend Not Covered by Earnings: The TTM payout ratio of 132.24% indicates dividends exceed reported net income, raising a red flag about long-term sustainability without robust and consistent free cash flow support.
- Severe Technical Downtrend & Underperformance: The stock is down 8.43% over 3 months and 5.31% over 1 month, sharply underperforming the S&P 500 by 21.03 and 9.91 percentage points, respectively. Trading just 11.5% above its 52-week low signals strong negative momentum.
- Premium Valuation on Sales & Cash Flow: A Price/Sales ratio of 10.96x and P/CF ratio of 14.94x appear elevated for a REIT, especially one facing operator headwinds. This premium leaves little room for error if growth slows.
- Limited Analyst Coverage & Muted Sentiment: Only 3 analysts cover the stock, and recent ratings like 'Market Perform' and 'Sector Perform' indicate a lack of strong conviction for upside. This low coverage can lead to higher volatility and inefficient price discovery.
OHI Technical Analysis
The stock is in a pronounced downtrend, having declined 8.43% over the past three months and 5.31% over the past month, sharply underperforming the S&P 500 which gained 12.6% and 4.6% over the same periods, respectively. Currently trading at $43.67, the price sits just 11.5% above its 52-week low of $35.7, positioning it in the lower quartile of its annual range, which suggests potential oversold conditions but also reflects significant negative momentum and investor skepticism. Despite a positive 1-year return of 16.73%, this longer-term gain is overshadowed by the recent severe underperformance, indicating a strong bearish reversal from earlier highs. Recent momentum is decisively negative, with the stock down 5.31% in one month and 8.43% over three months, a stark divergence from its positive yearly performance and signaling a breakdown in the prior uptrend. This negative short-term momentum is corroborated by a beta of 0.587, indicating the stock has been less volatile than the market but has failed to participate in the recent broad rally, suggesting company-specific or sector-specific headwinds are at play. The relative strength figures, such as -21.03 over three months, confirm this pronounced weakness relative to the benchmark. Key technical support is clearly defined at the 52-week low of $35.7, while resistance lies at the 52-week high of $49.33. A breakdown below $35.7 would signal a continuation of the downtrend and potentially trigger further selling, whereas a recovery above the recent high near $49 would be needed to invalidate the bearish structure. The stock's low beta of 0.587 implies it is about 41% less volatile than the S&P 500, which, combined with the high dividend yield, may attract income-focused investors during this decline, but does not mitigate the clear technical breakdown.
Beta
0.58
0.58x market volatility
Max Drawdown
-10.9%
Largest decline past year
52-Week Range
$36-$49
Price range past year
Annual Return
+26.1%
Cumulative gain past year
| Period | OHI Return | S&P 500 |
|---|---|---|
| 1m | -3.9% | +1.5% |
| 3m | -3.7% | +13.4% |
| 6m | +2.2% | +10.9% |
| 1y | +26.1% | +24.5% |
| ytd | +2.2% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OHI Fundamental Analysis
Revenue growth has been robust, with Q4 2025 revenue of $321.8 million representing a 15.22% year-over-year increase, continuing a multi-quarter acceleration from the $279.3 million reported in Q4 2024. This growth trajectory is supported by the company's portfolio expansion and improved operator performance, as indicated by the sequential quarterly revenue increases throughout 2025. The strong top-line expansion is a positive fundamental signal, suggesting the underlying real estate portfolio is generating increasing rental income, which is critical for a REIT's dividend coverage and asset value. Profitability is solid, with Q4 2025 net income of $164.7 million and a net margin of 51.18%, demonstrating the highly efficient conversion of revenue to earnings typical of a triple-net lease REIT model. The gross margin for the quarter was 47.22%, and the operating margin was a robust 63.49%, indicating strong operational leverage and cost control. While the payout ratio of 132.24% (TTM) shows dividends are currently not fully covered by earnings, the substantial free cash flow of $859.8 million (TTM) provides a more comprehensive picture of cash available for distributions. The balance sheet is healthy, with a conservative debt-to-equity ratio of 0.82 and a strong current ratio of 3.46, reflecting ample liquidity. Free cash flow of $859.8 million (TTM) significantly exceeds the dividend obligations, providing a strong cushion and financial flexibility. Return on equity of 11.39% is respectable for a REIT, indicating efficient use of shareholder capital, while the manageable debt level supports the company's ability to fund growth and maintain its dividend through internal cash generation.
Quarterly Revenue
$321817000.0B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.47%
Latest Quarter
Free Cash Flow
$859844000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OHI Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 22.25x, while the forward P/E is 21.41x, indicating the market expects modest earnings growth, with the slight compression reflecting stable but not accelerating future profitability expectations. The PEG ratio of 0.78, based on trailing figures, suggests the stock may be undervalued relative to its growth rate if that growth is sustainable. Compared to sector averages, OHI trades at a significant premium on a Price/Sales basis at 10.96x, though direct industry average comparisons are not provided in the data. Its P/CF ratio of 14.94x and EV/EBITDA of 14.84x provide alternative valuation lenses, with the latter in line with typical REIT valuations that often range from 12x to 18x. The dividend yield of 5.94% is a key valuation component for income investors and is attractive relative to the broader equity market and many other REITs, which may justify a premium for yield-seeking capital. Historically, the current trailing P/E of 22.25x is above the levels seen in early 2024 (around 19-24x) but has moderated from the higher 30x+ multiples observed in 2022-2023 during periods of earnings volatility. This suggests the valuation has normalized as earnings have recovered. The current P/B ratio of 2.53 is consistent with its recent historical range, indicating the market is pricing the equity at a stable premium to book value, which is typical for a REIT with a proven portfolio and reliable cash flows.
PE
22.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is the dividend payout ratio of 132.24%, which indicates dividends are not covered by net income. While free cash flow is strong, any material deterioration in operator rent collections or a rise in capital expenditures could pressure this coverage. Revenue, while growing at 15.22% YoY, is concentrated in the volatile post-acute care real estate sector, making it sensitive to changes in government reimbursement rates and operator bankruptcies. The company's earnings visibility is lower than typical REITs due to its dependence on third-party operator health. Market & Competitive Risks: OHI trades at a premium Price/Sales multiple of 10.96x, which is vulnerable to compression if growth decelerates or if interest rates rise, increasing the discount rate for future cash flows. The stock's low beta of 0.587 has not protected it from recent severe underperformance (-21.03 relative strength over 3 months), indicating company/sector-specific selling pressure. Competitive risks include other healthcare REITs and private capital vying for assets, potentially capping portfolio growth. Regulatory headwinds in the skilled nursing industry remain a persistent overhang. Worst-Case Scenario: The worst-case scenario involves a major operator default, triggering a simultaneous slowdown in revenue growth and a dividend cut due to cash flow pressures. This could lead to a re-rating to distressed valuation levels, with the stock revisiting its 52-week low of $35.70. From the current price of $43.67, this implies a potential downside of approximately -18%. A broader sector crisis, akin to concerns highlighted in recent news about peers like Medical Properties Trust, could exacerbate the sell-off, potentially pushing the stock even lower as investor confidence in healthcare REITs erodes.
FAQ
The key risks are, in order of severity: 1) Dividend Sustainability Risk: The payout ratio of 132.24% based on earnings is high, making the dividend vulnerable if cash flow falters. 2) Operator Concentration Risk: Revenue depends on the financial health of third-party healthcare operators, which are subject to reimbursement and labor pressures. 3) Sector & Regulatory Risk: The skilled nursing facility industry faces ongoing regulatory and reimbursement headwinds. 4) Valuation Compression Risk: Trading at a P/S of 10.96x, the stock could de-rate further if growth slows or sentiment towards healthcare REITs worsens.
The 12-month outlook presents three scenarios. The Base Case (60% probability) sees the stock trading between $43 and $47, as current fundamentals and risks balance out. The Bull Case (25% probability) targets a range of $49.33 to $52, driven by improved operator stability and dividend confidence. The Bear Case (15% probability) warns of a drop to the $35.70 to $40.00 range if operator issues materialize. The Base Case is most likely, assuming the company's substantial free cash flow continues to cover the dividend while sector overhangs persist.
OHI's valuation is mixed, leading to a fair value assessment. It appears potentially undervalued on a growth basis, with a PEG ratio of 0.78. However, it trades at a premium Price/Sales multiple of 10.96x and a P/CF of 14.94x. The forward P/E of 21.41x is in line with stable, cash-flowing REITs. The market is pricing in a premium for the yield but also a significant discount for operator and sector risks. Overall, the stock is fairly valued given the counterbalancing factors of strong cash flow and clear market skepticism.
OHI is a conditional buy for a specific investor profile. For an income-focused investor with a long-term horizon and tolerance for sector risk, the 5.94% yield supported by strong free cash flow ($859.8M TTM) can be attractive. However, given the recent severe underperformance (-8.43% over 3 months), elevated P/S ratio (10.96x), and dividend coverage concerns (132.24% payout ratio), it is not a compelling buy for growth investors or those seeking near-term capital appreciation. A prudent approach is to wait for technical stabilization before initiating a position.
OHI is primarily suitable for long-term investment. Its high dividend yield (5.94%) and business model are geared towards generating consistent income over time, not short-term trading gains. The stock's low beta (0.587) suggests lower volatility, which is characteristic of a hold-for-income asset. However, given the current technical downtrend and sector uncertainties, short-term trading is risky. A minimum holding period of 3-5 years is suggested to collect dividends and allow time for the fundamental story to potentially overcome near-term sentiment headwinds.

